UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Infosys
INFY
|
+$767M |
| 2 |
Amazon
AMZN
|
+$288M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$287M |
| 4 |
NVIDIA
NVDA
|
+$259M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$347M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$316M |
| 3 |
Citigroup
C
|
+$269M |
| 4 |
Charter Communications
CHTR
|
+$229M |
| 5 |
NetEase
NTES
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.35% |
| 2 | Consumer Discretionary | 13.14% |
| 3 | Financials | 12.19% |
| 4 | Healthcare | 12.04% |
| 5 | Communication Services | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Allegiant Air
ALGT
$2.57B
| $1.66M | ﹤0.01% |
6,800
+80
| +1% | +$17.8K |
|
1777
Rocket Pharmaceuticals
RCKT
$394M
| $1.66M | ﹤0.01% |
37,340
+1,869
| +5% | +$103K |
|
|
GWB
1778
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.64M | ﹤0.01% |
54,298
-5,875
| -10% | -$160K |
|
|
OSH
1779
DELISTED
Oak Street Health, Inc.
OSH
| $1.64M | ﹤0.01% |
30,233
+26,108
| +633% | +$1.45M |
|
|
LGF.A
1780
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $1.64M | ﹤0.01% |
109,387
+624
| +0.6% | +$9.36K |
|
1781
Northwest Bancshares
NWBI
$2.28B
| $1.63M | ﹤0.01% |
112,927
-42,382
| -27% | -$596K |
|
1782
Gray Television
GTN
$552M
| $1.63M | ﹤0.01% |
88,654
-5,432
| -6% | -$101K |
|
|
VGR
1783
DELISTED
Vector Group Ltd.
VGR
| $1.63M | ﹤0.01% |
164,743
| – | – |
|
1784
ADT
ADT
$5.58B
| $1.63M | ﹤0.01% |
193,047
-140,349
| -42% | -$1.22M |
|
1785
HNI Corp
HNI
$3.59B
| $1.62M | ﹤0.01% |
41,075
+2,363
| +6% | +$86.7K |
|
|
CRON
1786
Cronos Group
CRON
$1.14B
| $1.62M | ﹤0.01% |
+171,612
| New | +$1.82M |
|
1787
Inovio Pharmaceuticals
INO
$69M
| $1.62M | ﹤0.01% |
14,543
-1,625
| -10% | -$214K |
|
|
ECHO
1788
EchoStar
ECHO
$26.2B
| $1.61M | ﹤0.01% |
66,963
-21,440
| -24% | -$513K |
|
|
WDR
1789
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.61M | ﹤0.01% |
64,065
-38,940
| -38% | -$978K |
|
1790
Coca-Cola Consolidated
COKE
$12.8B
| $1.6M | ﹤0.01% |
55,470
| – | – |
|
1791
Heron Therapeutics
HRTX
$92.9M
| $1.6M | ﹤0.01% |
98,569
+4,171
| +4% | +$74.4K |
|
1792
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $1.59M | ﹤0.01% |
43,966
+5,593
| +15% | +$195K |
|
1793
Medifast
MED
$141M
| $1.59M | ﹤0.01% |
7,502
| – | – |
|
1794
Perdoceo Education
PRDO
$2.12B
| $1.58M | ﹤0.01% |
132,257
-7,600
| -5% | -$96.1K |
|
|
NARI
1795
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $1.58M | ﹤0.01% |
14,759
+10,959
| +288% | +$1.14M |
|
1796
Malibu Boats
MBUU
$567M
| $1.58M | ﹤0.01% |
19,803
| – | – |
|
1797
TriMas Corp
TRS
$1.44B
| $1.57M | ﹤0.01% |
51,878
+4,642
| +10% | +$153K |
|
1798
Palantir
PLTR
$413B
| $1.57M | ﹤0.01% |
67,427
+7,493
| +13% | +$205K |
|
1799
Unisys
UIS
$217M
| $1.57M | ﹤0.01% |
61,753
+3,156
| +5% | +$78K |
|
1800
St. Joe Company
JOE
$3.83B
| $1.56M | ﹤0.01% |
36,477
-1,408
| -4% | -$67.3K |
|
Similar funds
UBS AM's Q1 2021 Portfolio in Review
As of Q1 2021, UBS AM held 2,645 positions worth $226B, up 6% from $213B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 4.9%. UBS AM opened 86 new positions and exited 44, leaving the 2,645-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.
- UBS AM's largest Q1 2021 buy was Seagen Inc. Common Stock: 966,114 shares worth $134M.
- UBS AM added most to Infosys in Q1 2021, an estimated $767M increase.
- UBS AM's biggest Q1 2021 reduction was Alibaba, cutting an estimated $347M.
- UBS AM fully exited Lumen in Q1 2021, selling an estimated $45.5M.
- UBS AM's ten largest holdings make up 22% of its $226B portfolio in Q1 2021.
- UBS AM opened 86 new positions and closed 44 in Q1 2021.
- UBS AM's portfolio value rose 6% quarter-over-quarter to $226B.
Based on UBS AM's 13F filing for Q1 2021, filed 14 May 2021.